Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 58
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Food Microbiol ; 45(Pt B): 167-78, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25500382

ABSTRACT

Microbial life abounds on surfaces in both natural and industrial environments, one of which is the food industry. A solid substrate, water and some nutrients are sufficient to allow the construction of a microbial fortress, a so-called biofilm. Survival strategies developed by these surface-associated ecosystems are beginning to be deciphered in the context of rudimentary laboratory biofilms. Gelatinous organic matrices consisting of complex mixtures of self-produced biopolymers ensure the cohesion of these biological structures and contribute to their resistance and persistence. Moreover, far from being just simple three-dimensional assemblies of identical cells, biofilms are composed of heterogeneous sub-populations with distinctive behaviours that contribute to their global ecological success. In the clinical field, biofilm-associated infections (BAI) are known to trigger chronic infections that require dedicated therapies. A similar belief emerging in the food industry, where biofilm tolerance to environmental stresses, including cleaning and disinfection/sanitation, can result in the persistence of bacterial pathogens and the recurrent cross-contamination of food products. The present review focuses on the principal mechanisms involved in the formation of biofilms of food-borne pathogens, where biofilm behaviour is driven by its three-dimensional heterogeneity and by species interactions within these biostructures, and we look at some emergent control strategies.


Subject(s)
Bacterial Infections/microbiology , Bacterial Physiological Phenomena , Biofilms , Foodborne Diseases/microbiology , Bacteria/isolation & purification , Food Microbiology , Humans
2.
J Hosp Infect ; 144: 75-84, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38040038

ABSTRACT

BACKGROUND: The contagiousness of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is known to be linked to the emission of bioaerosols. Thus, aerosol-generating procedures (AGPs) could increase the risk of infection among healthcare workers (HCWs). AIM: To investigate the impact of an aerosol protection box, the SplashGuard Caregiver (SGGC) with suction system, by direct analysis of the presence of viral particles after an AGP, and by using the computational fluid dynamics (CFD) simulation method. METHODS: This prospective observational study investigated HCWs caring for patients with SARS-CoV-2 admitted to an intensive care unit (ICU). Rooms were categorized as: SGCG present and SGCG absent. Virus detection was performed through direct analysis, and using a CFD model to simulate the movement dynamics of airborne particles produced by a patient's respiratory activities. FINDINGS: Of the 67 analyses performed, three samples tested positive on quantitative polymerase chain reaction: one of 33 analyses in the SCCG group (3%) and two of 34 analyses in the non-SGCG group (5.9%). CFD simulations showed that: (1) reduction of the gaps of an SGCG could decrease the number of emitted particles remaining airborne within the room by up to 70%; and (2) positioning HCWs facing the opposite direction to the main air flow would reduce their exposure. CONCLUSIONS: This study documented the presence of SARS-CoV-2 among HCWs in a negative pressure ICU room of an infected patient with or without the use of an SGCG. The simulation will help to improve the design of the SGCG and the positioning of HCWs in the room.


Subject(s)
COVID-19 , SARS-CoV-2 , Humans , COVID-19/prevention & control , Caregivers , Prospective Studies , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Respiratory Aerosols and Droplets , Intensive Care Units
3.
Biotechnol Bioeng ; 109(5): 1280-92, 2012 May.
Article in English | MEDLINE | ID: mdl-22124974

ABSTRACT

The ability for a biofilm to grow and function is critically dependent on the nutrient availability, and this in turn is dependent on the structure of the biofilm. This relationship is therefore an important factor influencing biofilm maturation. Nutrient transport in bacterial biofilms is complex; however, mathematical models that describe the transport of particles within biofilms have made three simplifying assumptions: the effective diffusion coefficient (EDC) is constant, the EDC is that of water, and/or the EDC is isotropic. Using a Monte Carlo simulation, we determined the EDC, both parallel to and perpendicular to the substratum, within 131 real, single species, three-dimensional biofilms that were constructed from confocal laser scanning microscopy images. Our study showed that diffusion within bacterial biofilms was anisotropic and depth dependent. The heterogeneous distribution of bacteria varied between and within species, reducing the rate of diffusion of particles via steric hindrance. In biofilms with low porosity, the EDCs for nutrient transport perpendicular to the substratum were significantly lower than the EDCs for nutrient transport parallel to the substratum. Here, we propose a reaction-diffusion model to describe the nutrient concentration within a bacterial biofilm that accounts for the depth dependence of the EDC.


Subject(s)
Bacteria/chemistry , Bacteria/growth & development , Bacterial Physiological Phenomena , Biofilms/growth & development , Organic Chemicals/analysis , Diffusion , Models, Statistical
4.
Antimicrob Agents Chemother ; 55(6): 2648-54, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21422224

ABSTRACT

The biocidal activity of peracetic acid (PAA) and benzalkonium chloride (BAC) on Pseudomonas aeruginosa biofilms was investigated by using a recently developed confocal laser scanning microscopy (CLSM) method that enables the direct and real-time visualization of cell inactivation within the structure. This technique is based on monitoring the loss of fluorescence that corresponds to the leakage of a fluorophore out of cells due to membrane permeabilization by the biocides. Although this approach has previously been used with success with various Gram-positive species, it is not directly applicable to the visualization of Gram-negative strains such as P. aeruginosa, particularly because of limitations regarding fluorescence staining. After adapting the staining procedure to P. aeruginosa, the action of PAA and BAC on the biofilm formed by strain ATCC 15442 was investigated. The results revealed specific inactivation patterns as a function of the mode of action of the biocides. While PAA treatment triggered a uniform loss of fluorescence in the structure, the action of BAC was first localized at the periphery of cell clusters and then gradually spread throughout the biofilm. Visualization of the action of BAC in biofilms formed by three clinical isolates then confirmed the presence of a delay in penetration, showing that diffusion-reaction limitations could provide a major explanation for the resistance of P. aeruginosa biofilms to this biocide. Biochemical analysis suggested a key role for extracellular matrix characteristics in these processes.


Subject(s)
Benzalkonium Compounds/pharmacology , Biofilms/drug effects , Disinfectants/pharmacology , Peracetic Acid/pharmacology , Pseudomonas aeruginosa/drug effects , Drug Resistance, Bacterial , Microscopy, Confocal , Pseudomonas aeruginosa/physiology
5.
Biofouling ; 27(9): 1017-32, 2011 Oct.
Article in English | MEDLINE | ID: mdl-22011093

ABSTRACT

A biofilm can be defined as a community of microorganisms adhering to a surface and surrounded by a complex matrix of extrapolymeric substances. It is now generally accepted that the biofilm growth mode induces microbial resistance to disinfection that can lead to substantial economic and health concerns. Although the precise origin of such resistance remains unclear, different studies have shown that it is a multifactorial process involving the spatial organization of the biofilm. This review will discuss the mechanisms identified as playing a role in biofilm resistance to disinfectants, as well as novel anti-biofilm strategies that have recently been explored.


Subject(s)
Biofilms , Disinfectants , Drug Resistance, Microbial , Adaptation, Biological , Equipment and Supplies/microbiology
6.
Ann Oncol ; 21(4): 808-814, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19825885

ABSTRACT

BACKGROUND: The aim was to identify predictors of outcome in patients with localized prostate cancer treated with external beam radiotherapy (EBRT), with or without androgen deprivation therapy (ADT). MATERIALS AND METHODS: A total of 448 patients with prostate cancer received EBRT alone (n = 361, group 1) or ADT followed by EBRT (n = 87, group 2). In group 2, ADT was initiated 3 months before EBRT. After baseline prostate-specific antigen (PSA) determination (PSA(preRT)), PSA was assessed during the 6th week of the EBRT course (PSA(6wRT)) in group 1. In group 2, PSA was measured again 3 months after the start of ADT, before EBRT (PSA(ADT-preRT)). RESULTS: In group 1, median PSA(6wRT)/PSA(preRT) was 0.72 and median prostate-specific antigen velocity (PSAV) was -1.5 ng/ml/month. In the multivariate analysis, prognostic groups and PSA(6wRT)/PSA(preRT) (or PSAV) independently predicted biochemical failure (BF), clinical failure (CF), and prostate cancer-specific survival. In group 2, the median PSA(ADT-preRT) was 1.3 ng/ml. In the high-risk group, an undetectable PSA(ADT-preRT) (< or =0.2 ng/ml) predicted BF (P < 0.01) and CF (P = 0.007). CONCLUSION: A PSA decline 6 weeks after the start of EBRT when used as monotherapy and 3 months after the start of ADT in patients treated with combined ADT and EBRT is predictive of progression and specific survival.


Subject(s)
Adenocarcinoma/drug therapy , Adenocarcinoma/radiotherapy , Androgen Antagonists/therapeutic use , Prostate-Specific Antigen/blood , Prostatic Neoplasms/drug therapy , Prostatic Neoplasms/radiotherapy , Adenocarcinoma/blood , Adenocarcinoma/diagnosis , Aged , Aged, 80 and over , Antineoplastic Agents, Hormonal/therapeutic use , Brachytherapy , Combined Modality Therapy , Down-Regulation , Early Diagnosis , Humans , Male , Middle Aged , Prognosis , Prostatectomy , Prostatic Neoplasms/blood , Prostatic Neoplasms/diagnosis , Retrospective Studies , Survival Analysis , Time Factors , Treatment Failure
7.
Arch Pediatr ; 26(3): 174-175, 2019 Apr.
Article in French | MEDLINE | ID: mdl-30827776

ABSTRACT

Over the past 10 years, continuous positive airway pressure (CPAP) has revolutionized the prognosis and management of bronchiolitis patients hospitalized in pediatric intensive care units (PICUs). High-flow nasal cannula (HFNC) is emerging as an alternative to CPAP. Despite encouraging results of several clinical and physiological studies, HFNC use remains controversial and its indications heterogeneous. To better define the place of HFNC in severe bronchiolitis respiratory support, we investigated the different ventilation assistance techniques used for severe bronchiolitis over 3 days at the peak of a bronchiolitis epidemic in December 2015. We conducted an observational cross-sectional study in 27 French university hospital PICUs. Fifty-nine patients were included. The results show that HFNC already accounts for nearly half of the respiratory support techniques used for severe bronchiolitis in French PICUs with no significant difference between the CPAP group and the HFNC group of patients.


Subject(s)
Bronchiolitis/therapy , Oxygen Inhalation Therapy/methods , Bronchiolitis/epidemiology , Continuous Positive Airway Pressure/statistics & numerical data , Cross-Sectional Studies , France/epidemiology , Humans , Infant , Intensive Care Units, Pediatric , Oxygen Inhalation Therapy/statistics & numerical data
8.
Radiat Prot Dosimetry ; 131(1): 93-9, 2008.
Article in English | MEDLINE | ID: mdl-18757901

ABSTRACT

This article proposes an innovative multichannel optically stimulated luminescence (OSL) dosemeter for on-line in vivo dose verification in radiation therapy. OSL fibre sensors incorporating small Al(2)O(3):C fibre crystals (TLD(500)) have been tested with an X-ray generator. A reproducible readout procedure should reduce the fading-induced uncertainty ( approximately - 1% per decade). OSL readouts are temperature-dependent [ approximately 0.3% K(-1) when OSL stimulation is performed at the same temperature as irradiation; approximately 0.16% K(-1) after thermalisation (20 degrees C)]. Sensor calibration and depth-dose measurements with electron beams have been performed with a Saturne 43 linear accelerator in reference conditions at CEA-LNHB (ionising radiation reference laboratory in France). Predosed OSL sensors show a good repeatability in multichannel operation and independence versus electron energy in the range (9, 18 MeV). The difference between absorbed doses measured by OSL and an ionisation chamber were within +/-0.9% (for a dose of about 1 Gy) despite a sublinear calibration curve.


Subject(s)
Aluminum Oxide , Carbon , Radiotherapy Dosage , Radiotherapy , Thermoluminescent Dosimetry/instrumentation , Algorithms , Calibration , Humans , Monte Carlo Method , Particle Accelerators , Temperature , Uncertainty
9.
Arch Pediatr ; 14(10): 1213-5, 2007 Oct.
Article in French | MEDLINE | ID: mdl-17644355

ABSTRACT

Staphylococcus aureus is often responsible for late septic infections, more rarely of toxinic ones, occurring in neonatal period. We report a case of staphylococcal scalded skin syndrome and bullous impetigo in newborn twins infected by breast milk from their asymptomatic mother. This transmission was confirmed by molecular biology method. This case emphasizes the potential part of the mother in staphylococcal nosocomial infections and the complexity of toxinic mechanisms.


Subject(s)
Breast Feeding/adverse effects , Impetigo/etiology , Milk, Human/microbiology , Skin Diseases, Vesiculobullous/microbiology , Staphylococcal Scalded Skin Syndrome/etiology , Adult , Female , Humans , Infant, Newborn , Twins
10.
J Natl Cancer Inst ; 76(6): 1333-5, 1986 Jun.
Article in English | MEDLINE | ID: mdl-3520077

ABSTRACT

Lung shielding by lead blocks for reducing the dose to the lungs in whole-body irradiation results in relative protection of the leukemia cell population. The consequence is acceptable if the dose reduction is moderate (from 10 to 8 Gy) and if the shielded volume amounts to a small fraction (5%) of the body weight. The suggestion was made that certain limits should be put on the extent of shielding, so that the shielded lung fraction represents only 60% of the total lung volume.


Subject(s)
Lung/radiation effects , Radiation Protection/methods , Whole-Body Irradiation/methods , Humans , Lung/diagnostic imaging , Radiation Dosage , Tomography, X-Ray Computed
11.
J Clin Oncol ; 18(5): 981-6, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10694547

ABSTRACT

PURPOSE: Fractionated total-body irradiation (HTBI) is considered to induce less toxicity to normal tissues and probably has the same efficacy as single-dose total-body irradiation (STBI) in patients with acute myeloid leukemia. We decided to determine whether this concept can be applied to a large number of patients with various hematologic malignancies using two dissimilar fractionation schedules. PATIENTS AND METHODS: Between December 1986 and October 1994, 160 patients with various hematologic malignancies were randomized to receive either a 10-Gy dose of STBI or 14.85-Gy dose of HTBI. RESULTS: One hundred forty-seven patients were assessable. The 8-year overall survival rate and cause-specific survival rate in the STBI group was 38% and 63.5%, respectively. Overall survival rate and cause-specific survival rate in the HTBI group was 45% and 77%, respectively. The incidence of interstitial pneumonitis was similar in both groups. However, the incidence of veno-occlusive disease (VOD) of the liver was significantly higher in the STBI group. In the multivariate analysis with overall survival as the end point, the female sex was an independent favorable prognostic factor. On the other hand, when cause-specific survival was considered as the end point, the multivariate analysis demonstrated that sex and TBI were independent prognostic factors. CONCLUSION: The efficacy of HTBI is probably higher than that of STBI. Both regimens induce similar toxicity with the exception of VOD of the liver, the incidence of which is significantly more pronounced in the STBI group.


Subject(s)
Hematologic Neoplasms/radiotherapy , Whole-Body Irradiation/methods , Adolescent , Adult , Dose Fractionation, Radiation , Female , Hematologic Neoplasms/mortality , Humans , Male , Multivariate Analysis , Radiation Dosage , Survival Analysis
12.
Int J Food Microbiol ; 213: 2-16, 2015 Nov 20.
Article in English | MEDLINE | ID: mdl-26163933

ABSTRACT

The better understanding of the functioning of microbial communities is a challenging and crucial issue in the field of food microbiology, as it constitutes a prerequisite to the optimization of positive and technological microbial population functioning, as well as for the better control of pathogen contamination of food. Heterogeneity appears now as an intrinsic and multi-origin feature of microbial populations and is a major determinant of their beneficial or detrimental functional properties. The understanding of the molecular and cellular mechanisms behind the behavior of bacteria in microbial communities requires therefore observations at the single-cell level in order to overcome "averaging" effects inherent to traditional global approaches. Recent advances in the development of fluorescence-based approaches dedicated to single-cell analysis provide the opportunity to study microbial communities with an unprecedented level of resolution and to obtain detailed insights on the cell structure, metabolism activity, multicellular behavior and bacterial interactions in complex communities. These methods are now increasingly applied in the field of food microbiology in different areas ranging from research laboratories to industry. In this perspective, we reviewed the main fluorescence-based tools used for single-cell approaches and their concrete applications with specific focus on food microbiology.


Subject(s)
Food Microbiology/methods , Optical Imaging/methods , Single-Cell Analysis/methods , Bacteria/growth & development , Flow Cytometry , Fluorescence , Lab-On-A-Chip Devices , Microbial Consortia/physiology
13.
Bioelectrochemistry ; 106(Pt A): 133-40, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26026839

ABSTRACT

The long-term operation of efficient bioanodes supplied with waste-derived organics is a key challenge for using bioelectrochemical systems as a waste valorization technology. Here, we describe a simple procedure that allowed maintaining highly efficient bioanodes supplied with biowaste. Current densities up to 14.8 A/m(2) were obtained with more than 40% of the electrons introduced as biowaste being recovered in the electrical circuit. Three fed-batch reactors were started at different biowaste loading rates. A decline of coulombic efficiencies between 22 and 31% was recorded depending on the reactor over the first 3 weeks of operation. A renewal procedure of the anode was thereafter implemented, which led to a recovery of initial performances. The second and the third renewal, allowed maintaining stable high level performances with coulombic efficiency of approximately 40% over at least 3 weeks. Electroactive biofilm dynamics were monitored using 16S rRNA-gene amplicon sequencing. Retrieved sequences were dominated by Geobacter sulfurreducens-related reads (37% of total sequences), which proportion however varied along the experiment. Interestingly, sequences affiliated to various Bacteroidetes groups were also abundant, suggesting an adaptation of the anodic biofilm to the degradation of biowaste through metabolic interactions between microbial community members.


Subject(s)
Bioelectric Energy Sources/microbiology , Electric Conductivity , Geobacter/metabolism , Waste Products , Electrochemistry , Electrodes , Geobacter/genetics , RNA, Ribosomal, 16S/genetics , Sequence Analysis, RNA
14.
Int J Radiat Oncol Biol Phys ; 32(4): 1177-83, 1995 Jul 15.
Article in English | MEDLINE | ID: mdl-7607940

ABSTRACT

PURPOSE: The development of a scattering system for a proton therapy beam line dedicated to ophthalmological applications. METHODS AND MATERIALS: A protontherapy beam line has been developed for the treatment of uveal melanoma at the Orsay synchrocyclotron. The original 200 MeV proton beam is degraded to 76 MeV and the final beam characteristics (range, modulation, flatness, collimation) are obtained with beam modifiers in the treatment room. A passive scattering system is used to obtain a uniform dose distribution in the beam cross-section throughout 30 mm in diameter, with minimal losses in energy and dose rate. We have used an experimental approach for the scattering study. RESULTS: An elliptical ring shaped from 0.1-mm thick lead is the solution we have adopted for the scattering system. For a modulated beam, a flatness of 1% is obtained on transverse profiles. The energy loss introduced by this scatterer is only 0.5 MeV, with no appreciable change in the range over the treatment field. For an unmodulated beam, 21% of intensity is lost when the scatterer is used. The distal and the lateral dose fall-off (90-10%) for a modulated beam are 2.6 mm. These last values are independent of the range and the modulation currently used for the ophthalmic applications. CONCLUSION: A specific passive scattering system can be adapted to a particular beam emittance. A systematic experimental approach can easily be undertaken to obtain the scatterer adapted for small irradiation fields in proton therapy.


Subject(s)
Ophthalmology/instrumentation , Proton Therapy , Scattering, Radiation , Uveal Neoplasms/radiotherapy , Equipment Design
15.
Int J Radiat Oncol Biol Phys ; 30(4): 821-4, 1994 Nov 15.
Article in English | MEDLINE | ID: mdl-7960983

ABSTRACT

PURPOSE: To evaluate the incidence of lung complications and leukemia recurrences after two different doses to the lungs during total body irradiation. METHODS AND MATERIALS: Seventy-nine patients with acute leukemia (AML or ALL) in first complete remission or chronic myeloid leukemia in the chronic phase, five patients with high grade lymphoma, and one with chronic lymphocytic leukemia were entered in the study. They were given a single dose of total body irradiation (10 Gy over 4 h) with two different doses to the lungs (6 Gy or 8 Gy) prior to bone marrow transplantation. The median dose rate was 0.04 Gy/min. The median follow-up for both groups of patients was 24 months. RESULTS: The actuarial 5-year overall survival rate was similar in both groups, 59% and 43% for patients given 8 Gy and 6 Gy to the lungs, respectively. The lung complication rate was similar in the two groups (28% vs. 22% for the 8 Gy and 6 Gy group, respectively). The actuarial leukemia recurrence rate was significantly higher in the group of patients given 6 Gy to the lungs (25%) vs. 0% in the 8 Gy group. Interestingly, all recurrences occurred in the group of patients who were given 6 Gy to the lungs, who had acute leukemia, and no chronic graft vs. host disease (GVHD). CONCLUSIONS: Although the number of patients was not very large and the follow-up relatively short, these findings suggest that a lower dose to the lungs could lead to an increased incidence of leukemia recurrences due to a lower dose to the thoracic wall or to lower incidence of chronic GVHD.


Subject(s)
Leukemia/radiotherapy , Lung Neoplasms/etiology , Lung/radiation effects , Neoplasms, Radiation-Induced/etiology , Whole-Body Irradiation/adverse effects , Adolescent , Adult , Bone Marrow Transplantation , Child , Child, Preschool , Combined Modality Therapy , Cytomegalovirus Infections/etiology , Dose-Response Relationship, Radiation , Graft vs Host Disease/etiology , Humans , Leukemia/chemically induced , Leukemia/therapy , Leukemia, Lymphocytic, Chronic, B-Cell/complications , Leukemia, Lymphocytic, Chronic, B-Cell/radiotherapy , Leukemia, Lymphocytic, Chronic, B-Cell/therapy , Leukemia, Myeloid, Acute/complications , Leukemia, Myeloid, Acute/radiotherapy , Leukemia, Myeloid, Acute/therapy , Leukemia, Myeloid, Chronic-Phase/complications , Leukemia, Myeloid, Chronic-Phase/radiotherapy , Leukemia, Myeloid, Chronic-Phase/therapy , Lung/microbiology , Lung Diseases, Interstitial/etiology , Lung Diseases, Interstitial/microbiology , Middle Aged , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Precursor Cell Lymphoblastic Leukemia-Lymphoma/radiotherapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy
16.
Int J Radiat Oncol Biol Phys ; 46(1): 123-9, 2000 Jan 01.
Article in English | MEDLINE | ID: mdl-10656383

ABSTRACT

PURPOSE: Biological dosimetry based on scoring chromosomal aberrations in peripheral lymphocytes was compared to physical dosimetry done for total body irradiation (TBI) before bone marrow transplantation (BMT) in patients with hematologic malignancies. PATIENTS AND METHODS: Fifteen patients undergoing TBI were included in the study. A total dose of 12 Gy in 2.5 days was fractionated into 2 or 3 daily doses of 1.8 Gy delivered by a 18 MV linear accelerator (dose rate: 15.8 cGy x min(-1)). Blood samples were obtained from patients before irradiation and after the first fraction of 1.8 Gy. A standard dose-effect curve was established by in vitro irradiation of healthy volunteer lymphocytes. Chromosomal aberrations were scored by the conventional cytogenetics (CCG) method for unstable anomalies and by fluorescent in situ hybridization (FISH) for stable anomalies. RESULTS: Healthy donor lymphocytes before irradiation yielded 0.1% dicentrics and 0.3% translocations of chromosome 4 (Chr. 4), that is 2.5% for the whole genome. Patients before irradiation had 2% of dicentrics and 1.1% of chromosome 4 translocations. The biologically estimated dose of the 15 patients after exposure to 1.8 Gy was 1.93 Gy (95% CI: 1.85-2.05) according to CCG, and 2.06 Gy (95% CI: 1.75-2.15) by FISH. CONCLUSION: The dose estimated by biological dosimetry, in this case of homogeneously distributed radiation of TBI agrees well with the absorbed radiation dose calculated by physical dosimetry.


Subject(s)
Hematologic Neoplasms/radiotherapy , Radiometry/methods , Whole-Body Irradiation , Adult , Aged , Bone Marrow Transplantation , Chromosome Aberrations , Chromosomes, Human/radiation effects , Dose-Response Relationship, Radiation , Female , Hematologic Neoplasms/blood , Hematologic Neoplasms/genetics , Humans , In Situ Hybridization, Fluorescence , Lymphocytes/radiation effects , Male , Middle Aged
17.
Int J Radiat Oncol Biol Phys ; 37(3): 711-8, 1997 Feb 01.
Article in English | MEDLINE | ID: mdl-9112471

ABSTRACT

A comparison of the absorbed dose to tissue determined by various ionization chambers, Faraday cups, and an A-150 plastic calorimeter was performed in the 200 MeV proton beam of Orsay, France. Four European proton-therapy centers (Clatterbridge, UK, Louvain la Neuve, Belgium, and Nice and Orsay, France) participated in the comparison. An agreement of better than 1% was observed in the absorbed dose to A-150 measured with the different chambers of the participating groups. The mean ratio of the absorbed dose to A-150 determined with the calorimeter to that determined by the different ionization chambers in the different irradiation conditions was found to be 0.952 +/- 0.007 [1 standard deviation (SD)] according to the code of practice used by all the participating centers, based on Janni's tables of stopping powers and a value of 35.2 J/Coulomb for (W(air)/e)p. A better agreement in the mean ratio calorimeter/chamber, 0.985 +/- 0.007 (1 SD) is observed when using the proton stopping power ratio values recently published by the International Commission on Radiation Units and Measurements in Report no. 49. The mean ratio of these doses determined in accordance with the American Association of Physicists in Medicine protocol and using the new recommended stopping power tables becomes 1.002 +/- 0.007 (1 SD). Two Faraday cups agree in measured charge to within 0.8%; however, the calculation of dose is underestimated by up to 17%; compared with ion chamber measurements and seems to be very sensitive to measurement conditions, particularly to the distance to the collimator.


Subject(s)
Radiometry/methods , Calibration , Calorimetry , Ions , Radiation Dosage , Radiometry/instrumentation
18.
Int J Radiat Oncol Biol Phys ; 13(5): 789-93, 1987 May.
Article in English | MEDLINE | ID: mdl-3553114

ABSTRACT

A prospective evaluation of computed tomography and ultrasound was performed on 34 patients with Stage I and II endometrial carcinoma. All patients underwent immediate surgery following intracavitary treatment directed to vaginal mucosa. Pathologic measurements of the uterus were compared to those obtained by imaging technologies. The results of the study suggest that all but height measurements were rather accurately determined by both ultrasound and CT scan. However ultrasound was significantly better in determining the size of the cervix. Therefore ultrasound measurements could be used routinely for intracavitary treatment planning in endocervical carcinoma and endometrial carcinoma.


Subject(s)
Tomography, X-Ray Computed , Ultrasonography , Uterine Neoplasms/radiotherapy , Uterus/pathology , Brachytherapy , Combined Modality Therapy , Female , Humans , Neoplasm Staging , Prospective Studies , Radiotherapy Planning, Computer-Assisted , Uterine Neoplasms/diagnosis , Uterine Neoplasms/diagnostic imaging
19.
Radiother Oncol ; 18 Suppl 1: 16-29, 1990.
Article in English | MEDLINE | ID: mdl-2123356

ABSTRACT

Basic dosimetry as well as patient dosimetry are considered. The following items concerning the basic beam dosimetry are discussed: dosimetry calibration, phantom material, beam quality and depth dose measurements in TBI conditions. Dose to the patient should be specified to the midplane of the abdomen but dose to the lung should be estimated for each patient. In vivo, dosimetry is strongly recommended for determination of dose homogeneity, as well as to check patient position, reproducibility of treatment and instabilities in dose rate during TBI. Many physical problems are associated with in vivo dosimetry. All influences on the detector response have to be considered and the detectors must be calibrated for TBI conditions.


Subject(s)
Radiotherapy Dosage , Whole-Body Irradiation/methods , Absorption , Bone Marrow Transplantation , Humans , Models, Structural , Quality Control , Radiation , Radiation Protection , Radiotherapy, High-Energy/methods
20.
Radiother Oncol ; 29(3): 308-16, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8127981

ABSTRACT

A simple method to estimate the contribution of contaminating electrons to the dose, and to evaluate their dosimetric characteristics is proposed. The method is based on a normalisation of the tissue--maximum ratio curves to a constant primary photon fluence. The contribution of the contaminating electrons to the dose is calculated by subtracting the dose relative to a small field from the dose relative to the field under consideration. The method includes the determination of the mean energy, the linear apparent attenuation coefficient, the 50% range and the maximum range of the contaminating electrons. The extrapolated surface dose normalised to a constant primary photon fluence has been found to be constant for a constant collimator opening whatever may be the source distance.


Subject(s)
Electrons , Photons , Radiotherapy Dosage , Radiotherapy, High-Energy , Skin/radiation effects , Absorption , Energy Transfer , Humans , Models, Biological , Models, Structural , Models, Theoretical , Particle Accelerators , Scattering, Radiation , X-Rays
SELECTION OF CITATIONS
SEARCH DETAIL